Media Center
Stories
News
May 11, 2018
Cellectar receives orphan drug designation for CLR 131 to treat rhabdomyosarcoma, a rare pediatric cancer
Cellectar Biosciences has announced that the U.S. Food and Drug Administration (FDA) […]
May 7, 2018
U-M startup Give and Take in Inc… “How to Build a Better Company With More Engaged Employees in Just 5 Minutes a Day”
Givitas can make asking for and getting help from other employees simple […]
May 7, 2018
NanoBio closes $10M funding round, changes name to BlueWillow Biologics, and plans to take NanoVax nasal spray vaccine platform into clinical trials
Ann Arbor-based NanoBio Corp., considered by many as perhaps the most successful […]
April 6, 2018
Boston Scientific buys U-M startup Securus for $40M to add to heart imaging lineup
Medical device giant Boston Scientific has acquired Securus Medical Group, a startup […]
March 21, 2018
TIME: U-M’s nasal flu vaccine, FluMist, is set to come back next year
After a two-year hiatus, the nasal flu vaccine is set to return […]
March 16, 2018
U-M startup ViewPoint Therapeutics raises $35 Million in Series B financing
ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin […]